Table of Content

1 Report Overview
1.1 Immunity Nutraceutical Ingredient Definition
1.2 Market by Type
1.2.1 Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Minerals
1.2.3 Omega-3 fatty acids
1.2.4 Carotenoids
1.2.5 Fibers & specialty carbohydrates
1.2.6 Phytochemical and plant extracts
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Functional food
1.3.3 Functional beverages
1.3.4 Dietary supplements
1.3.5 Animal nutrition
1.3.6 Personal care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Immunity Nutraceutical Ingredient Sales
2.1 Global Immunity Nutraceutical Ingredient Revenue Estimates and Forecasts 2018-2034
2.2 Global Immunity Nutraceutical Ingredient Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Immunity Nutraceutical Ingredient Revenue by Region
2.3.1 Global Immunity Nutraceutical Ingredient Revenue by Region (2018-2024)
2.3.2 Global Immunity Nutraceutical Ingredient Revenue by Region (2024-2034)
2.4 Global Immunity Nutraceutical Ingredient Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Immunity Nutraceutical Ingredient Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Immunity Nutraceutical Ingredient Sales Quantity by Region
2.6.1 Global Immunity Nutraceutical Ingredient Sales Quantity by Region (2018-2024)
2.6.2 Global Immunity Nutraceutical Ingredient Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Immunity Nutraceutical Ingredient Sales Quantity by Manufacturers
3.1.1 Global Immunity Nutraceutical Ingredient Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Immunity Nutraceutical Ingredient Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Immunity Nutraceutical Ingredient Sales in 2022
3.2 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers
3.2.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2018-2024)
3.2.2 Global Immunity Nutraceutical Ingredient Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Immunity Nutraceutical Ingredient Revenue in 2022
3.3 Global Immunity Nutraceutical Ingredient Sales Price by Manufacturers
3.4 Global Key Players of Immunity Nutraceutical Ingredient, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immunity Nutraceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immunity Nutraceutical Ingredient, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immunity Nutraceutical Ingredient, Product Offered and Application
3.8 Global Key Manufacturers of Immunity Nutraceutical Ingredient, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Immunity Nutraceutical Ingredient Sales Quantity by Type
4.1.1 Global Immunity Nutraceutical Ingredient Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Immunity Nutraceutical Ingredient Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
4.2 Global Immunity Nutraceutical Ingredient Revenue by Type
4.2.1 Global Immunity Nutraceutical Ingredient Historical Revenue by Type (2018-2024)
4.2.2 Global Immunity Nutraceutical Ingredient Forecasted Revenue by Type (2024-2034)
4.2.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
4.3 Global Immunity Nutraceutical Ingredient Price by Type
4.3.1 Global Immunity Nutraceutical Ingredient Price by Type (2018-2024)
4.3.2 Global Immunity Nutraceutical Ingredient Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Immunity Nutraceutical Ingredient Sales Quantity by Application
5.1.1 Global Immunity Nutraceutical Ingredient Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Immunity Nutraceutical Ingredient Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
5.2 Global Immunity Nutraceutical Ingredient Revenue by Application
5.2.1 Global Immunity Nutraceutical Ingredient Historical Revenue by Application (2018-2024)
5.2.2 Global Immunity Nutraceutical Ingredient Forecasted Revenue by Application (2024-2034)
5.2.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
5.3 Global Immunity Nutraceutical Ingredient Price by Application
5.3.1 Global Immunity Nutraceutical Ingredient Price by Application (2018-2024)
5.3.2 Global Immunity Nutraceutical Ingredient Price Forecast by Application (2024-2034)
6 North America
6.1 North America Immunity Nutraceutical Ingredient Sales by Company
6.1.1 North America Immunity Nutraceutical Ingredient Revenue by Company (2018-2024)
6.1.2 North America Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024)
6.2 North America Immunity Nutraceutical Ingredient Market Size by Type
6.2.1 North America Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2034)
6.2.2 North America Immunity Nutraceutical Ingredient Revenue by Type (2018-2034)
6.3 North America Immunity Nutraceutical Ingredient Market Size by Application
6.3.1 North America Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2034)
6.3.2 North America Immunity Nutraceutical Ingredient Revenue by Application (2018-2034)
6.4 North America Immunity Nutraceutical Ingredient Market Size by Country
6.4.1 North America Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Immunity Nutraceutical Ingredient Revenue by Country (2018-2034)
6.4.3 North America Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunity Nutraceutical Ingredient Sales by Company
7.1.1 Europe Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024)
7.1.2 Europe Immunity Nutraceutical Ingredient Revenue by Company (2018-2024)
7.2 Europe Immunity Nutraceutical Ingredient Market Size by Type
7.2.1 Europe Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2034)
7.2.2 Europe Immunity Nutraceutical Ingredient Revenue by Type (2018-2034)
7.3 Europe Immunity Nutraceutical Ingredient Market Size by Application
7.3.1 Europe Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2034)
7.3.2 Europe Immunity Nutraceutical Ingredient Revenue by Application (2018-2034)
7.4 Europe Immunity Nutraceutical Ingredient Market Size by Country
7.4.1 Europe Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Immunity Nutraceutical Ingredient Revenue by Country (2018-2034)
7.4.3 Europe Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Immunity Nutraceutical Ingredient Sales by Company
8.1.1 China Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024)
8.1.2 China Immunity Nutraceutical Ingredient Revenue by Company (2018-2024)
8.2 China Immunity Nutraceutical Ingredient Market Size by Type
8.2.1 China Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2034)
8.2.2 China Immunity Nutraceutical Ingredient Revenue by Type (2018-2034)
8.3 China Immunity Nutraceutical Ingredient Market Size by Application
8.3.1 China Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2034)
8.3.2 China Immunity Nutraceutical Ingredient Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Immunity Nutraceutical Ingredient Sales by Company
9.1.1 APAC Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024)
9.1.2 APAC Immunity Nutraceutical Ingredient Revenue by Company (2018-2024)
9.2 APAC Immunity Nutraceutical Ingredient Market Size by Type
9.2.1 APAC Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2034)
9.2.2 APAC Immunity Nutraceutical Ingredient Revenue by Type (2018-2034)
9.3 APAC Immunity Nutraceutical Ingredient Market Size by Application
9.3.1 APAC Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2034)
9.3.2 APAC Immunity Nutraceutical Ingredient Revenue by Application (2018-2034)
9.4 APAC Immunity Nutraceutical Ingredient Market Size by Region
9.4.1 APAC Immunity Nutraceutical Ingredient Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Immunity Nutraceutical Ingredient Revenue by Region (2018-2034)
9.4.3 APAC Immunity Nutraceutical Ingredient Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales by Company
10.1.1 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Market Size by Type
10.2.1 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Market Size by Application
10.3.1 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Market Size by Country
10.4.1 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Koninklijke DSM N.V. (Netherlands)
11.1.1 Koninklijke DSM N.V. (Netherlands) Company Information
11.1.2 Koninklijke DSM N.V. (Netherlands) Overview
11.1.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Products and Services
11.1.5 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient SWOT Analysis
11.1.6 Koninklijke DSM N.V. (Netherlands) Recent Developments
11.2 Ingredion Incorporated (U.S)
11.2.1 Ingredion Incorporated (U.S) Company Information
11.2.2 Ingredion Incorporated (U.S) Overview
11.2.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Products and Services
11.2.5 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient SWOT Analysis
11.2.6 Ingredion Incorporated (U.S) Recent Developments
11.3 Ajinomoto Co., Inc. (Japan)
11.3.1 Ajinomoto Co., Inc. (Japan) Company Information
11.3.2 Ajinomoto Co., Inc. (Japan) Overview
11.3.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Products and Services
11.3.5 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient SWOT Analysis
11.3.6 Ajinomoto Co., Inc. (Japan) Recent Developments
11.4 Arla Foods (Denmark)
11.4.1 Arla Foods (Denmark) Company Information
11.4.2 Arla Foods (Denmark) Overview
11.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Products and Services
11.4.5 Arla Foods (Denmark) Immunity Nutraceutical Ingredient SWOT Analysis
11.4.6 Arla Foods (Denmark) Recent Developments
11.5 Tate & Lyle PLC (U.K)
11.5.1 Tate & Lyle PLC (U.K) Company Information
11.5.2 Tate & Lyle PLC (U.K) Overview
11.5.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Products and Services
11.5.5 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient SWOT Analysis
11.5.6 Tate & Lyle PLC (U.K) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Immunity Nutraceutical Ingredient Value Chain Analysis
12.2 Immunity Nutraceutical Ingredient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunity Nutraceutical Ingredient Production Mode & Process
12.4 Immunity Nutraceutical Ingredient Sales and Marketing
12.4.1 Immunity Nutraceutical Ingredient Sales Channels
12.4.2 Immunity Nutraceutical Ingredient Distributors
12.5 Immunity Nutraceutical Ingredient Customers
13 Market Dynamics
13.1 Immunity Nutraceutical Ingredient Industry Trends
13.2 Immunity Nutraceutical Ingredient Market Drivers
13.3 Immunity Nutraceutical Ingredient Market Challenges
13.4 Immunity Nutraceutical Ingredient Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Minerals
Table 3. Major Manufacturers of Omega-3 fatty acids
Table 4. Major Manufacturers of Carotenoids
Table 5. Major Manufacturers of Fibers & specialty carbohydrates
Table 6. Major Manufacturers of Phytochemical and plant extracts
Table 7. Major Manufacturers of Others
Table 8. Global Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Immunity Nutraceutical Ingredient Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Immunity Nutraceutical Ingredient Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2018-2024)
Table 12. Global Immunity Nutraceutical Ingredient Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2024-2034)
Table 14. Global Immunity Nutraceutical Ingredient Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 15. Global Immunity Nutraceutical Ingredient Sales by Region (2018-2024) & (MT)
Table 16. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2018-2024)
Table 17. Global Immunity Nutraceutical Ingredient Sales by Region (2024-2034) & (MT)
Table 18. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2024-2034)
Table 19. Global Immunity Nutraceutical Ingredient Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 20. Global Immunity Nutraceutical Ingredient Sales Quantity Share by Manufacturers (2018-2024)
Table 21. Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Immunity Nutraceutical Ingredient Revenue Share by Manufacturers (2018-2024)
Table 23. Global Immunity Nutraceutical Ingredient Price by Manufacturers 2018-2024 (USD/Kg)
Table 24. Global Key Players of Immunity Nutraceutical Ingredient, Industry Ranking, 2021 VS 2022
Table 25. Global Immunity Nutraceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Immunity Nutraceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunity Nutraceutical Ingredient as of 2022)
Table 27. Global Key Manufacturers of Immunity Nutraceutical Ingredient, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Immunity Nutraceutical Ingredient, Product Offered and Application
Table 29. Global Key Manufacturers of Immunity Nutraceutical Ingredient, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 32. Global Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 33. Global Immunity Nutraceutical Ingredient Sales Quantity Share by Type (2018-2024)
Table 34. Global Immunity Nutraceutical Ingredient Sales Quantity Share by Type (2024-2034)
Table 35. Global Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Immunity Nutraceutical Ingredient Revenue Share by Type (2018-2024)
Table 38. Global Immunity Nutraceutical Ingredient Revenue Share by Type (2024-2034)
Table 39. Immunity Nutraceutical Ingredient Price by Type (2018-2024) & (USD/Kg)
Table 40. Global Immunity Nutraceutical Ingredient Price Forecast by Type (2024-2034) & (USD/Kg)
Table 41. Global Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 42. Global Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 43. Global Immunity Nutraceutical Ingredient Sales Quantity Share by Application (2018-2024)
Table 44. Global Immunity Nutraceutical Ingredient Sales Quantity Share by Application (2024-2034)
Table 45. Global Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Immunity Nutraceutical Ingredient Revenue Share by Application (2018-2024)
Table 48. Global Immunity Nutraceutical Ingredient Revenue Share by Application (2024-2034)
Table 49. Immunity Nutraceutical Ingredient Price by Application (2018-2024) & (USD/Kg)
Table 50. Global Immunity Nutraceutical Ingredient Price Forecast by Application (2024-2034) & (USD/Kg)
Table 51. North America Immunity Nutraceutical Ingredient Revenue by Company (2018-2024) & (US$ Million)
Table 52. North America Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024) & (MT)
Table 53. North America Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 54. North America Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 55. North America Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 56. North America Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 58. North America Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 59. North America Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 60. North America Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 62. North America Immunity Nutraceutical Ingredient Revenue by Country (2018-2024) & (US$ Million)
Table 63. North America Immunity Nutraceutical Ingredient Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2024) & (MT)
Table 65. North America Immunity Nutraceutical Ingredient Sales Quantity by Country (2024-2034) & (MT)
Table 66. Europe Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024) & (MT)
Table 67. Europe Immunity Nutraceutical Ingredient Revenue by Company (2018-2024) & (US$ Million)
Table 68. Europe Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 69. Europe Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 70. Europe Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 71. Europe Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 73. Europe Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 74. Europe Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 75. Europe Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 77. Europe Immunity Nutraceutical Ingredient Revenue by Country (2018-2024) & (US$ Million)
Table 78. Europe Immunity Nutraceutical Ingredient Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2024) & (MT)
Table 80. Europe Immunity Nutraceutical Ingredient Sales Quantity by Country (2024-2034) & (MT)
Table 81. China Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024) & (MT)
Table 82. China Immunity Nutraceutical Ingredient Revenue by Company (2018-2024) & (US$ Million)
Table 83. China Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 84. China Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 85. China Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 86. China Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 88. China Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 89. China Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 90. China Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024) & (MT)
Table 92. APAC Immunity Nutraceutical Ingredient Revenue by Company (2018-2024) & (US$ Million)
Table 93. APAC Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 94. APAC Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 95. APAC Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 96. APAC Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 98. APAC Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 99. APAC Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 100. APAC Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Immunity Nutraceutical Ingredient Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 102. APAC Immunity Nutraceutical Ingredient Revenue by Region (2018-2024) & (US$ Million)
Table 103. APAC Immunity Nutraceutical Ingredient Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Immunity Nutraceutical Ingredient Sales Quantity by Region (2018-2024) & (MT)
Table 105. APAC Immunity Nutraceutical Ingredient Sales Quantity by Region (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Company (2018-2024) & (MT)
Table 107. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Company (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Type (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Type (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Type (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Application (2018-2024) & (MT)
Table 113. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Application (2024-2034) & (MT)
Table 114. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Application (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Country (2018-2024) & (US$ Million)
Table 118. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Country (2018-2024) & (MT)
Table 120. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity by Country (2024-2034) & (MT)
Table 121. Koninklijke DSM N.V. (Netherlands) Company Information
Table 122. Koninklijke DSM N.V. (Netherlands) Description and Overview
Table 123. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 124. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product and Services
Table 125. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient SWOT Analysis
Table 126. Koninklijke DSM N.V. (Netherlands) Recent Developments
Table 127. Ingredion Incorporated (U.S) Company Information
Table 128. Ingredion Incorporated (U.S) Description and Overview
Table 129. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 130. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product and Services
Table 131. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient SWOT Analysis
Table 132. Ingredion Incorporated (U.S) Recent Developments
Table 133. Ajinomoto Co., Inc. (Japan) Company Information
Table 134. Ajinomoto Co., Inc. (Japan) Description and Overview
Table 135. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 136. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product and Services
Table 137. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient SWOT Analysis
Table 138. Ajinomoto Co., Inc. (Japan) Recent Developments
Table 139. Arla Foods (Denmark) Company Information
Table 140. Arla Foods (Denmark) Description and Overview
Table 141. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 142. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product and Services
Table 143. Arla Foods (Denmark) Immunity Nutraceutical Ingredient SWOT Analysis
Table 144. Arla Foods (Denmark) Recent Developments
Table 145. Tate & Lyle PLC (U.K) Company Information
Table 146. Tate & Lyle PLC (U.K) Description and Overview
Table 147. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 148. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product and Services
Table 149. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient SWOT Analysis
Table 150. Tate & Lyle PLC (U.K) Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Immunity Nutraceutical Ingredient Distributors List
Table 154. Immunity Nutraceutical Ingredient Customers List
Table 155. Immunity Nutraceutical Ingredient Market Trends
Table 156. Immunity Nutraceutical Ingredient Market Drivers
Table 157. Immunity Nutraceutical Ingredient Market Challenges
Table 158. Immunity Nutraceutical Ingredient Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunity Nutraceutical Ingredient Product Picture
Figure 2. Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Immunity Nutraceutical Ingredient Market Share by Type in 2022 & 2034
Figure 4. Minerals Product Picture
Figure 5. Omega-3 fatty acids Product Picture
Figure 6. Carotenoids Product Picture
Figure 7. Fibers & specialty carbohydrates Product Picture
Figure 8. Phytochemical and plant extracts Product Picture
Figure 9. Others Product Picture
Figure 10. Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 11. Global Immunity Nutraceutical Ingredient Market Share by Application in 2022 & 2034
Figure 12. Functional food
Figure 13. Functional beverages
Figure 14. Dietary supplements
Figure 15. Animal nutrition
Figure 16. Personal care
Figure 17. Immunity Nutraceutical Ingredient Report Years Considered
Figure 18. Global Immunity Nutraceutical Ingredient Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 19. Global Immunity Nutraceutical Ingredient Revenue 2018-2034 (US$ Million)
Figure 20. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 21. Global Immunity Nutraceutical Ingredient Sales Quantity 2018-2034 (MT)
Figure 22. Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Region (2018-2024)
Figure 23. Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Immunity Nutraceutical Ingredient Sales Quantity YoY (2018-2034) & (MT)
Figure 25. North America Immunity Nutraceutical Ingredient Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Immunity Nutraceutical Ingredient Sales Quantity YoY (2018-2034) & (MT)
Figure 27. Europe Immunity Nutraceutical Ingredient Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Immunity Nutraceutical Ingredient Sales Quantity YoY (2018-2034) & (MT)
Figure 29. China Immunity Nutraceutical Ingredient Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Immunity Nutraceutical Ingredient Sales Quantity YoY (2018-2034) & (MT)
Figure 31. APAC Immunity Nutraceutical Ingredient Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity YoY (2018-2034) & (MT)
Figure 33. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Immunity Nutraceutical Ingredient Sales Quantity in 2022
Figure 35. The Top 10 and Top 5 Players Market Share by Immunity Nutraceutical Ingredient Revenue in 2022
Figure 36. Immunity Nutraceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 39. Global Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 41. North America Immunity Nutraceutical Ingredient Revenue Market Share by Company in 2022
Figure 42. North America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Company in 2022
Figure 43. North America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 45. North America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 47. North America Immunity Nutraceutical Ingredient Revenue Share by Country (2018-2034)
Figure 48. North America Immunity Nutraceutical Ingredient Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Immunity Nutraceutical Ingredient Sales Quantity Market Share by Company in 2022
Figure 52. Europe Immunity Nutraceutical Ingredient Revenue Market Share by Company in 2022
Figure 53. Europe Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 55. Europe Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 57. Europe Immunity Nutraceutical Ingredient Revenue Share by Country (2018-2034)
Figure 58. Europe Immunity Nutraceutical Ingredient Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 60. France Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 64. China Immunity Nutraceutical Ingredient Sales Quantity Market Share by Company in 2022
Figure 65. China Immunity Nutraceutical Ingredient Revenue Market Share by Company in 2022
Figure 66. China Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 68. China Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 70. APAC Immunity Nutraceutical Ingredient Sales Quantity Market Share by Company in 2022
Figure 71. APAC Immunity Nutraceutical Ingredient Revenue Market Share by Company in 2022
Figure 72. APAC Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 74. APAC Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 76. APAC Immunity Nutraceutical Ingredient Revenue Share by Region (2018-2034)
Figure 77. APAC Immunity Nutraceutical Ingredient Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 82. India Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue Market Share by Company in 2022
Figure 85. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Immunity Nutraceutical Ingredient Revenue Share by Country (2018-2034)
Figure 91. Brazil Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Immunity Nutraceutical Ingredient Revenue (2018-2034) & (US$ Million)
Figure 96. Immunity Nutraceutical Ingredient Value Chain
Figure 97. Immunity Nutraceutical Ingredient Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed